DNMT1 and cardiovascular disorder: The reported beneficial effects of EGCG have led to its exploitation in clinical trials as a dietary supplement to improve endothelial function in humans with coronary artery disease to decrease the risk of cardiovascular diseases [88] and as a natural non-nucleoside inhibitor of DNA methyl-transferase 1 (DNMT1) [71].